Table 3.

Overall experience: relationship between proportion of subjects having megakaryocytic progenitor cells hypersensitive to PEG-rHu MGDF and presumptive diagnosis

Presumptive diagnosis
HealthyET3-1502°T3-151PV
No. of subjects 22 26 8  
No. with low and flat responses3-152 1  
No. with high and flat responses3-153 3  
No. quantitatively informative 21 20 4  
No. hypersensitive to PEG-rHu MGDF 18 0  
Overall percentage hypersensitive to PEG-rHu MGDF 0/22 = 0% 18/26 = 69.2% 1/9 = 11.1% 0/8 = 0% 
Percentage of quantitatively informative subjects hypersensitive to PEG-rHu MGDF 0/21 = 0% 18/20 = 90.0% 1/8 = 12.5% 0/4 = 0% 
Presumptive diagnosis
HealthyET3-1502°T3-151PV
No. of subjects 22 26 8  
No. with low and flat responses3-152 1  
No. with high and flat responses3-153 3  
No. quantitatively informative 21 20 4  
No. hypersensitive to PEG-rHu MGDF 18 0  
Overall percentage hypersensitive to PEG-rHu MGDF 0/22 = 0% 18/26 = 69.2% 1/9 = 11.1% 0/8 = 0% 
Percentage of quantitatively informative subjects hypersensitive to PEG-rHu MGDF 0/21 = 0% 18/20 = 90.0% 1/8 = 12.5% 0/4 = 0% 
F3-150

Essential (primary) thrombocythemia.

F3-151

Secondary (reactive) thrombocytosis.

F3-152

No significant increase in colony no. with increase in cytokine concentration; usually = ≤5 colonies per culture.

F3-153

No significant increase in colony no. with increase in cytokine concentration; usually = ≥25 colonies per culture.

or Create an Account

Close Modal
Close Modal